Table 1.
The relationship between miR-7 expression and clinicopathologic characteristics in pancreatic cancer patients.
| Clinicopathologic variable | miR-7 | P value | |
|---|---|---|---|
| Low expression | High expression | ||
| Age (y) | 0.637 | ||
| ≤50 | 7 | 11 | |
| >50 | 30 | 52 | |
| Gender | 0.855 | ||
| Female | 12 | 25 | |
| Male | 25 | 38 | |
| Tumor size (cm)[a] | 0.645 | ||
| ≤2 | 0 | 2 | |
| >2 | 37 | 59 | |
| Tumor differentiation | 0.015∗ | ||
| Well/moderate | 19 | 49 | |
| Poor | 18 | 14 | |
| TNM stage[b] | 0.028∗ | ||
| I+II | 35 | 62 | |
| III+IV | 2 | 0 | |
| Lymph node metastasis[c] | 0.930 | ||
| Negative | 20 | 31 | |
| Positive | 15 | 24 | |
| Distant metastasis | 0.011∗ | ||
| Negative | 35 | 63 | |
| Positive | 2 | 0 | |
| Lymphovascular invasion | 0.875 | ||
| Absent | 21 | 37 | |
| Present | 16 | 26 | |
∗Statistically significant (P < 0.05). [a]2 patients' information missing; [b]1 patient's information missing; [c]10 patients' information missing.